Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
Sponsor: Massachusetts General Hospital
Summary
The SUGAR-MGH investigators are studying the influence of inherited gene variants on the response to two commonly prescribed type 2 diabetes medications, metformin and glipizide. They hypothesize that variants in genes that are associated with type 2 diabetes or related traits may impact the effect of anti-diabetic medications. In addition, physiological responses to an insulin secretagogue or an insulin sensitizer may shed light on the mechanism of action of reported genetic associations.
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
1033
Start Date
2008-01
Completion Date
2025-12
Last Updated
2025-05-08
Healthy Volunteers
Yes
Conditions
Interventions
Glipizide
Metformin
Oral Glucose Tolerance Test
Locations (3)
Massachusetts General Hospital
Boston, Massachusetts, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Joslin Diabetes Center
Boston, Massachusetts, United States